2009 ASCO Annual Meeting Abstracts
http://www.abstract.asco.org/CatAbstView_65_78_AA.html
For us there is an abstract of the Prof. Judson about development of his cediranib study in ASPS patients some of them we know personally
Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma.
http://www.abstract.asco.org/AbstView_65_30688.html
Full text with the time to progression and progression-free survival will be calculated and available at the time of presentation, I hope to get it later, our oncologist is attending.
2009 ASCO Annual Meeting
Re: 2009 ASCO Annual Meeting
Olga,
Thanks for posting this. Our oncologist is also attending this meeting and I look forward to
our next appt. It seems this will be a great opportunity for them to share info. and learn from
one another about the trial data. We are still participating in ARQ.
Cindy
Thanks for posting this. Our oncologist is also attending this meeting and I look forward to
our next appt. It seems this will be a great opportunity for them to share info. and learn from
one another about the trial data. We are still participating in ARQ.
Cindy